Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PID Controller01:19

PID Controller

Proportional-Integral-Derivative (PID) controllers are widely used in various control systems to enhance stability and performance. In a thermostat, it adjusts heating or cooling based on the temperature difference between the actual and desired levels. They are often used in automotive speed systems, effectively managing sudden speed changes while maintaining a constant speed under varying conditions. On the other hand, PI controllers, commonly employed in voltage regulation, enhance stability...
PD Controller: Design01:26

PD Controller: Design

In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
Profile Leveling and Cross Sections01:26

Profile Leveling and Cross Sections

Profile leveling and cross-sections are surveying methods used to determine and document terrain elevations for infrastructure projects such as highways, railroads, canals, and pipelines. These methods provide data for earthwork planning and alignment of proposed routes.  Profile leveling involves measuring elevations along a fixed line to create a vertical terrain profile. A surveyor sets up a leveling instrument at the benchmark (BM) and records a backsight (BS) to determine the instrument's...
pV-Diagrams01:18

pV-Diagrams

The pV diagram, which is a graph of pressure versus volume of the gas under study, is helpful in describing certain aspects of the substance. When the substance behaves like an ideal gas, the ideal gas equation describes the relationship between its pressure and volume. On a pV diagram, it is common to plot an isotherm, which is a curve showing p as a function of V with the number of molecules and the temperature fixed. Then, for an ideal gas, the product of the pressure of the gas and its...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysis.

Scientific reports·2024
Same author

Pharmacogenomic Innovative Solutions.

Personalized medicine·2018
Same author

Joint Cold Spring Harbor Laboratory/Wellcome Trust Conference on Pharmacogenomics.

Personalized medicine·2018
Same author

Pharmacogenomics: past, present & future. Interview by Theo Bond.

Pharmacogenomics·2013
Same author

Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar.

Pharmacogenetics and genomics·2007

Related Experiment Video

Updated: May 29, 2026

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions
10:58

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

Company profile: PGXIS Ltd.

Alun McCarthy1

  • 1PGXIS Ltd, Aston Court, Kingsmead Business Park, Frederick Place, High Wycombe, Bucks HP111LA, UK. alun.mccarthy@pgxis.com

Pharmacogenomics
|September 17, 2011
PubMed
Summary
This summary is machine-generated.

Pharmacogenomic Innovative Solutions Ltd (PGXIS) offers expert pharmacogenomic (PGx) services and novel analysis tools like Taxonomy3. Their integrated methodologies enhance drug development for biotech and pharmaceutical partners.

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Quantitative Characterization of Liquid Photosensitive Bioink Properties for Continuous Digital Light Processing Based Printing
04:32

Quantitative Characterization of Liquid Photosensitive Bioink Properties for Continuous Digital Light Processing Based Printing

Published on: April 14, 2023

Related Experiment Videos

Last Updated: May 29, 2026

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions
10:58

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Quantitative Characterization of Liquid Photosensitive Bioink Properties for Continuous Digital Light Processing Based Printing
04:32

Quantitative Characterization of Liquid Photosensitive Bioink Properties for Continuous Digital Light Processing Based Printing

Published on: April 14, 2023

Area of Science:

  • Pharmacogenomics
  • Biotechnology
  • Pharmaceutical Sciences

Background:

  • Pharmacogenomic Innovative Solutions Ltd (PGXIS) was founded in 2007 by pharmacogenomic experts.
  • The company aims to provide specialized pharmacogenomic expertise to the biotechnology and pharmaceutical industries.
  • PGXIS has expanded its network to include a broad range of PGx knowledge and technologies.

Purpose of the Study:

  • To offer advanced pharmacogenomic solutions for drug development.
  • To integrate novel analytical tools and methodologies for enhanced drug discovery.
  • To leverage a network of experts for comprehensive PGx knowledge access.

Main Methods:

  • Development of Taxonomy3, a multivariate analysis tool for data integration and targeting.
  • Integration of siRNA methodology from CytoPathfinder Inc.
  • Application of diverse pharmacogenomic methodologies.

Main Results:

  • Established a comprehensive suite of pharmacogenomic methodologies.
  • Developed a novel multivariate analysis tool (Taxonomy3).
  • Broadened access to PGx knowledge and technologies through an expert network.

Conclusions:

  • PGXIS provides extensive pharmacogenomic expertise and tools.
  • The company's integrated methodologies, including Taxonomy3 and siRNA, are designed to optimize drug development processes.
  • PGXIS is positioned to significantly impact drug development through advanced pharmacogenomic solutions.